Clinical Trials

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06964568 2026-04-17

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Phase 3 Recruiting

452 enrolled

Esophageal Neoplasms

NCT06601309 2025-09-15

ESCC

Phase 2 Recruiting

90 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07055841 2025-07-09

Single-Arm Exploratory Study of PD-L1 Antibody Plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 2 Recruiting

69 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03201861 2025-05-16

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Phase 3 Recruiting

762 enrolled

Breast

Carcinoma, Ductal, Breast

NCT04460352 2025-03-06

NEEDS

Phase 3 Recruiting

1,020 enrolled

Phase 2 Not yet recruiting

Esophageal Squamous Cell Carcinoma

NCT06713057 2024-12-03

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

20 enrolled

Phase 2 Active not recruiting

Thyroid Neoplasms

NCT05520619 2024-11-18

EC-CRT-002

114 enrolled

Phase NA Not yet recruiting

Esophageal Squamous Cell Carcinoma

NCT06649448 2024-10-18

EF-001

200 enrolled

Other solid neoplasm

Solid Tumor Cancer

NCT06588335 2024-09-19

BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Phase 2 Not yet recruiting

20 enrolled

Esophageal Squamous Cell Carcinoma

NCT06138028 2024-07-24

Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer

Phase 2/3 Recruiting

90 enrolled

Esophageal Squamous Cell Carcinoma

NCT04409860 2023-04-11

CQGOG0102

Phase NA Recruiting

120 enrolled

Uterine Cervical Neoplasms

NCT04005170 2022-08-23

Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer

Phase 2 Completed

42 enrolled

Esophageal Squamous Cell Carcinoma

NCT04625543 2022-04-26

Neoadjuvant Immunotherapy to ESCC

Phase 2 Withdrawn

Esophageal Squamous Cell Carcinoma

NCT02459457 2022-02-09

A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

Phase 3 Completed

321 enrolled

Esophageal Squamous Cell Carcinoma

NCT00582205 2021-05-19

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

Phase 2 Terminated

21 enrolled 7 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT01126216 2021-05-04

Paccis-RCT

Phase 3 Terminated

221 enrolled

Head and Neck Neoplasms

NCT04588090 2020-10-19

A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity.

Phase NA Unknown

200 enrolled

Uterine Cervical Neoplasms

NCT04499118 2020-08-05

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Phase 2 Unknown

100 enrolled

Breast

Breast Neoplasms

NCT01216111 2020-05-19

Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)

Phase 3 Completed

647 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Phase 2 Unknown

44 enrolled

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

NCT03927495 2019-05-29

KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

100 enrolled

Esophageal Squamous Cell Carcinoma

NCT01534585 2018-04-17

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Phase 1/2 Completed

48 enrolled

Nasopharyngeal Carcinoma

NCT03468010 2018-03-26

A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)

432 enrolled

Uterine Cervical Neoplasms, Lymphatic Metastasis

NCT01704690 2017-04-07

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Phase 2/3 Terminated

4 enrolled

Esophageal Neoplasms

NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

486 enrolled

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

NCT00933387 2016-05-04

A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma

Phase 2 Completed

47 enrolled

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT01393080 2016-02-17

NSCLC

Phase NA Unknown

160 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00801736 2013-12-10

ET

Phase 3 Terminated

648 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00818090 2013-04-12

Paclitaxel and Cisplatin for Thymic Neoplasm

Phase 2 Terminated

39 enrolled

Thoracic

Thymic epithelial tumor, Thymoma

NCT01593306 2012-05-08

Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix

80 enrolled

Uterine Cervical Neoplasms

NCT01405235 2012-04-12

AGO-Zervix-1

312 enrolled

Recurrence

NCT00779714 2008-10-24

ChemoSensMM